LDOS insider: 3,345 shares acquired via option exercise; prior Form 4 amended
Rhea-AI Filing Summary
Noel B. Geer, a director of Leidos Holdings, Inc. (LDOS), exercised stock options and corrected a prior Form 4 attribution error. The filing reports an option exercise on 08/27/2025 that resulted in acquisition of 3,345 shares at an exercise price of $75.02 per share. After the transaction the report shows total beneficial ownership of 37,018.8435 shares, comprised of 37,018.8435 shares directly (adjusted) with 2,000 shares held indirectly by spouse and 32,000 shares held indirectly by a Family Trust. The filing also corrects a November 8, 2023 Form 4 to reclassify a prior sale of 2,106 shares from indirect Family Trust ownership to direct ownership by the reporting person.
Positive
- Director increased direct ownership by acquiring 3,345 shares through option exercise on 08/27/2025 at $75.02 per share
- Correction improves disclosure accuracy by reclassifying a November 6, 2023 sale of 2,106 shares from indirect Family Trust ownership to direct ownership
Negative
- None.
Insights
TL;DR: Director exercised options for 3,345 shares at $75.02 and corrected a past filing; impact appears immaterial to company fundamentals.
The reported exercise increases the director's direct share count by 3,345 shares and results in a stated post-transaction beneficial ownership of 37,018.8435 shares. The filing explicitly corrects an administrative attribution error from a 2023 Form 4 concerning 2,106 shares. These actions are routine director-level equity transactions and bookkeeping correction; no new financial metrics or operational changes are disclosed that would alter revenue, earnings, or debt positions.
TL;DR: The Form 4 correction improves disclosure accuracy; the option exercise is a standard insider equity event without governance red flags.
The correction reallocates 2,106 shares from indirect Family Trust ownership to the reporting person's direct holdings, which strengthens the transparency of insider holdings history. The exercise of stock options with a $75.02 exercise price on 08/27/2025 is documented and signed under power of attorney. No departures, new related-party transactions, or control changes are reported.